|
KIF16B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64712687933388E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.41495712316464E-12 |
| Normal-vs-Stage2 |
3.648900E-04 |
| Normal-vs-Stage3 |
1.42189593432818E-11 |
| Normal-vs-Stage4 |
1.63080660087189E-12 |
| Stage1-vs-Stage2 |
9.513700E-02 |
| Stage1-vs-Stage3 |
2.746800E-01 |
| Stage1-vs-Stage4 |
1.420110E-04 |
| Stage2-vs-Stage3 |
3.334300E-02 |
| Stage2-vs-Stage4 |
4.782700E-04 |
| Stage3-vs-Stage4 |
2.091800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0956127378422E-13 |
| Normal-vs-AfricanAmerican |
5.61239999999907E-05 |
| Normal-vs-Asian |
4.40758540776187E-13 |
| Caucasian-vs-AfricanAmerican |
5.684000E-01 |
| Caucasian-vs-Asian |
1.868030E-02 |
| AfricanAmerican-vs-Asian |
3.371700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.26485497023532E-13 |
| Normal-vs-Female |
2.89124280072883E-12 |
| Male-vs-Female |
3.562200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.71418435002124E-12 |
| Normal-vs-Age(41-60Yrs) |
1.59450230796665E-11 |
| Normal-vs-Age(61-80Yrs) |
5.09009999705157E-08 |
| Normal-vs-Age(81-100Yrs) |
1.080820E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.858400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.509000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.299200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.643600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.693800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.369600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.022000E-04 |
| Classical-VS-Follicular |
3.254000E-02 |
| Classical-VS-Other |
2.976000E-01 |
| Classical-VS-Normal |
1.63524749297039E-12 |
| Tall-VS-Follicular |
3.71700000000308E-05 |
| Tall-VS-Other |
7.644000E-01 |
| Tall-VS-Normal |
1.75648384725946E-12 |
| Follicular-VS-Other |
1.559540E-02 |
| Follicular-VS-Normal |
2.007900E-04 |
| Other-VS-Normal |
3.600800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.78189718325461E-11 |
| Normal-vs-N1 |
2.28705943072782E-14 |
| N0-vs-N1 |
4.776300E-04 |
|
|
